Moclobemide and fluoxetine for panic disorder

European Archives of Psychiatry and Clinical Neuroscience

Volumn 249, Issue SUPPL., 1999, Pages

  Tiller, John W G ^b   Bouwer, Colin ^a   Behnke, Kirsten ^b  

^a DUNEDIN HOSPITAL   (New Zealand)

^b NONE

Author keywords

Fluoxetine; Moclobemide; Panic disorder; Tolerability; Treatment

Indexed keywords

FLUOXETINE; MOCLOBEMIDE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGITATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; GASTROENTERITIS; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PANIC; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS;

ADULT; BENZAMIDES; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HEADACHE; HUMANS; MALE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITORS; PANIC DISORDER; SEROTONIN UPTAKE INHIBITORS; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

EID: 0032970014     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00014164     Document Type: Article

References (10)

1. Angst J, Stabl M (1992) Efficacy of moclobemide in different patient groups: a meta-analysis of studies. Psychopharmacology 106 Suppl: 109-113
2. Buller R (1994) Presented at the ECNP, Jerusalem
3. Delini-Stula A, Mikkelsen H, Angst J (1995) Therapeutic efficacy of antidepressants in agitated, anxious depression - a metaanalysis of moclobemide studies. J Affect Disord 35: 21-30
4. Dunbar G, Judge R (1995) Long-term evaluation of paroxetine, clomipramine and placebo in panic disorders. Eur Neuropsychopharmacol 5: 361 (abstract P-5-27)
5. Dunbar G, Steiner M, Oakes R et al. (1995) A fixed dose study of paroxetine (10 mg, 20 mg, 40 mg) and placebo in the treatment of panic disorders. Eur Neuropsychopharmacol 5: 361 (abstract P-5-26)
6. Sotsky SM, Glass DR, Shea MT, Pilkonis PA, Collins JF, Elkin J, Watkins JT, Imber SD, Leber WR, Moyer Jet al. (1991) Patients predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry 8: 997-1008
7. Tyrer P, Candy J, Kelly DA (1973) A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety. Psychopharmacologia 32: 237-254
8. Versiani M, Nadi AE, Mundim FD, Alves AB, Liebowitz MR, Amrein R (1992) Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine. Br J Psychiatry 161: 353-360
9. Zitrin CM, Klein DF, Woerner MG, Mundim FD, Alves AB, Liebowitz MR, Amrein R (1980) Treatment of agoraphobia with group exposure in vivo and imipramine. Arch Gen Psychiatry 37: 63-72
10. Zitrin CM, Klein DF, Woerner MG, Ross DC (1983) Treatment of phobias: comparison of imipramine hydrochloride and placebo. Arch Gen Psychiatry 40: 125-138